population health

Research in Review

Novel Therapy Induces High Response Rate in Metastatic NSCLC

06/01/2017

JCP Editors

A novel antibody-drug conjugate is well tolerated and induces durable responses in pretreated patients with advanced non-small cell lung cancer (NSCLC), according to research published in the Journal of Clinical...

A...

06/01/2017

Journal of Clinical Pathways

Research in Review

Receipt of Head, Neck Cancer Supportive Services Varies by Hospital Type

06/01/2017

JCP Editors

Patients with head and neck cancer who do not receive supportive services are more likely to miss radiation therapy appointments and lose weight during treatment, according to research presented at the 2017 ASCO...

...

06/01/2017

Journal of Clinical Pathways

Real-World Data Shows Metastatic Bladder Cancer Survival Worse Than in Clinical Trials

05/31/2017

JCP Editors

Few patients with metastatic urothelial carcinoma of the bladder are surviving as long in the real-world as those in clinical trials, according to new research. Current overall survival projections for patients with...

Few...

05/31/2017

Journal of Clinical Pathways

Research in Review

Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing

05/31/2017

JCP Editors

Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...

Women...

05/31/2017

Journal of Clinical Pathways

Research in Review

B-Cell Malignancy Provides Economic Burden to US Commercial Payers

05/30/2017

JCP Editors

The high economic burden of B-cell malignancies on US commercial insurers may impact future reimbursement decisions, according to research that will be presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...

The...

05/30/2017

Journal of Clinical Pathways

Research in Review

HPV Vaccine Underutilized Despite Significant Oral HPV Infection Protection

05/30/2017

JCP Editors

Research presented at the 2017 American Society of Clinical Oncology showed that although human papillomavirus (HPV) vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and...

...

05/30/2017

Journal of Clinical Pathways

Research in Review

Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End-of-Life

05/26/2017

JCP Editors

Aggressive care within the last month of life for patients with non-small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care, according to new research. ----- Related...

...

05/26/2017

Journal of Clinical Pathways

Research in Review

Advanced Melanoma Increases Psychological Burden in Patients

05/25/2017

JCP Editors

Stage III and IV melanoma may have a profound impact on patients’ distress burden, which requires further intervention strategies, according to research that will be presented at the 2017 ASCO Annual Meeting...

Stage...

05/25/2017

Journal of Clinical Pathways

Research in Review

Triple Combination Active in High-Risk B-Cell Malignancies

05/24/2017

JCP Editors

A combination of 3 pathway inhibitors is well tolerated with activity observed in heavily pre-treated and high-risk B-cell malignancies, according to research that will be presented at the ASCO Annual Meeting (June...

A...

05/24/2017

Journal of Clinical Pathways

Research in Review

Increased Risk of Secondary Cancer for Survivors of Hodgkin Lymphoma

05/19/2017

JCP Editors

Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...

...

05/19/2017

Journal of Clinical Pathways